MOIR - Administrative Core
MOIR - Administrative Core
批准号:
10731662
负责人:
Rafick Pierre Sekaly
金额:
$9.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-03 至 2028-04-30
关键词:
AdherenceAgreementApplications GrantsBudgetsClinicalClinical ResearchCollaborationsCommunicationCommunitiesDataData SetData Storage and RetrievalDatabasesDepositionDisputesEnsureEnvironmentEthicsFosteringFundingFutureGoalsGrantHIVHumanImmunityImmunologyImmunotherapyInfrastructureInstitutionInstitutional Review BoardsIntellectual PropertyLaboratoriesLeadLeadershipLinkMachine LearningMetabolicModelingPostdoctoral FellowProductivityProgram EvaluationProgram Research Project GrantsProgress ReportsProperty RightsRecommendationRegulatory PathwayReproducibilityResearchResearch PersonnelResearch Project GrantsResearch SupportResource SharingResourcesRoleSamplingStudentsValidationViralWorkclinical research sitecollaborative environmentcommunity engagementconflict resolutiondata infrastructuredata managementdata sharingeducation resourcesepigenomicsimmunological interventioninnovationmaterial transfer agreementmeetingsmembermicrobiomemultiple omicsorganizational structureprogramssynergismtimelinetooltranscriptomicsweb site
中文摘要
摘要-行政核心
P01计划赠款的行政核心,题为“多OMIcs识别和验证
免疫干预引发的机制,旨在减少复制能力的大小
水库“(多组学免疫水库- MOIR)将提供科学,财政和监管监督所有
参与机构和临床研究中心的P01项目组成部分。此P01包含3个
研究项目,管理核心,机器学习和建模核心。的总体目标
行政核心是建立一个有组织的研究环境,促进合作互动
研究者之间,促进创新研究,并满足P01的关键目标。行政
核心将蓬勃发展,以确保科学工作计划的执行符合最高的道德标准,
遵循最严格的严谨性和可重复性原则。行政核心将完成这些任务
通过以下三个具体目标实现目标:1)为总体管理制定基础设施计划
P01活动的协调; 2)提供科学和财政监督,
进度报告,以确保P01符合规定的里程碑和时间表;以及
3)促进项目和核心之间的有效沟通和富有成效的互动。的
行政核心的组织基础设施包括行政核心理事会、
科学指导委员会(SC)和科学咨询委员会(SAB)。常设委员会成员(项目和
核心领导人)将负责科学监督、项目活动评估、伦理、科学
诚信和监管。ACC成员由项目首席PI和核心首席PI组成
P01和项目经理,将协调高度综合的科学议程,提供财政支持,
监督,管理科学界和非科学界之间的数据存储和数据共享,并建立
集中的网站,以促进内部和外部的P01社区的沟通。以促进
PI,博士后研究员,学生和研究支持人员之间的互动,行政核心将
组织月度和年度会议,讨论科学进展和计划活动。此外该
行政团队将确保正确执行和遵守所有合同协议(MTA和
与P01相关的IRB)。行政协调会和科学委员会将共同努力,
和核心,促进社区参与,协助解决冲突和争端,并实施战略
实现计划目标的方法。
英文摘要
ABSTRACT – ADMINISTRATIVE CORE
The Administrative core of the P01 program grant entitled “Multi-OMIcs identification and validation of
mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent
Reservoir “ (Multiomics Immunity Reservoir- MOIR) will provide scientific, fiscal, and regulatory oversight for all
components of the P01 program across the participating institutions and clinical sites. This P01 contains 3
Research Projects, an Administrative Core, and a Machine Learning and Modeling Core. The overall goal of the
administrative core is to establish an organized research environment that will foster collaborative interactions
between investigators, promote innovative research, and meet the key objectives of the P01. The administrative
core will thrive to ensure that scientific work plans are performed according to the highest ethical standards and
follow the most stringent principles of rigor and reproducibility. The Administrative core will accomplish these
goals through the following three specific aims: 1) Create an infrastructure plan for the overall management
and coordination of the P01 activities; 2) Provide scientific and fiscal oversight, and generate annual
progress reports to ensure that the P01 is in compliance with the stated milestones and timelines; and
3) Facilitate effective communication and foster productive interactions among Projects and Cores. The
organizational infrastructure of the Administration core consists of an Administration Core Council (ACC), a
scientific steering committee (SC), and a Scientific Advisory Board (SAB). The members of the SC (project and
core leaders) will be responsible for scientific oversight, evaluation of program activities, ethical, scientific
integrity and regulatory oversight. The ACC members, which consist of the Project and Core Lead PIs of the
P01 and the program manager, will coordinate the highly integrative scientific agenda, provide financial
oversight, manage data storage and data sharing among the scientific and lay community and establish a
centralized website to facilitate communication both within and outside the P01 community. To facilitate
interactions between PIs, postdoctoral fellows, students, and research support staff, the administrative core will
organize monthly and annual meetings to discuss scientific progress and program activities. In addition, the
administrative team will ensure the proper execution and adherence to all contractual agreements (MTA and
IRBs) associated with the P01. Together the ACC and SC will serve to maximize the synergy between projects
and cores, promote community engagement, assist in resolving conflicts and disputes, and implement a strategic
approach to accomplish the Program goals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MultiOMICS mechanistic identification of predictors of HIV DNA decay, restoration of immune homeostasis and HIV specific immunity in PWH with cancer receiving Immune check point therapy
-
批准号:10731665
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10588314
-
项目类别:
-
资助金额:$79.33万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
-
批准号:10731661
-
项目类别:
-
资助金额:$129.39万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
I2 Control= Modulating Innate Immunity to Achieve Control of HIV
-
批准号:10731664
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10429404
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2022
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10596182
-
项目类别:
-
资助金额:$8.72万
-
财政年份:2022
-
负责人:Rafick Pierre Sekaly
-
依托单位:
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials
-
批准号:10341373
-
项目类别:
-
资助金额:$104.7万
-
财政年份:2021
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.
-
批准号:10163555
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10222321
-
项目类别:
-
资助金额:$79.55万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir
-
批准号:10321500
-
项目类别:
-
资助金额:$74.39万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection
-
批准号:10321501
-
项目类别:
-
资助金额:$53.2万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10680632
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Core C - Modeling Core
-
批准号:10080706
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Core C - Modeling Core
-
批准号:10322684
-
项目类别:
-
资助金额:$40.56万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:9623814
-
项目类别:
-
资助金额:$87.52万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10198704
-
项目类别:
-
资助金额:$154.03万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:9979743
-
项目类别:
-
资助金额:$63.67万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10336870
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10463861
-
项目类别:
-
资助金额:$76.96万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Resetting immune homeostasis: a non-invasive approach towards HIV eradication
-
批准号:10303927
-
项目类别:
-
资助金额:$134.71万
-
财政年份:2017
-
负责人:Rafick Pierre Sekaly
-
依托单位:
海外基金